348 related articles for article (PubMed ID: 15493113)
21. Serum uric acid as prognostic marker of coronary heart disease (CHD).
Purnima S; El-Aal BG
Clin Investig Arterioscler; 2016; 28(5):216-224. PubMed ID: 27663421
[TBL] [Abstract][Full Text] [Related]
22. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications.
Puddu P; Puddu GM; Cravero E; Vizioli L; Muscari A
J Cardiol; 2012 May; 59(3):235-42. PubMed ID: 22398104
[TBL] [Abstract][Full Text] [Related]
23. Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study.
Viazzi F; Garneri D; Leoncini G; Gonnella A; Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Trimarco B; Volpe M; Agabiti Rosei E; Deferrari G; Pontremoli R
Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):921-7. PubMed ID: 24675005
[TBL] [Abstract][Full Text] [Related]
24. [Other antihyperuricemic agents].
Ogino K; Igawa O; Hisatome I
Nihon Rinsho; 2008 Apr; 66(4):754-7. PubMed ID: 18409527
[TBL] [Abstract][Full Text] [Related]
25. Uric acid in heart disease: a new C-reactive protein?
Krishnan E; Sokolove J
Curr Opin Rheumatol; 2011 Mar; 23(2):174-7. PubMed ID: 21178630
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular and renal effects of hyperuricaemia and gout.
Viazzi F; Leoncini G; Pontremoli R
Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532
[TBL] [Abstract][Full Text] [Related]
27. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Wachtell K; Hornestam B; Lehto M; Slotwiner DJ; Gerdts E; Olsen MH; Aurup P; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Rokkedal J; Devereux RB
J Am Coll Cardiol; 2005 Mar; 45(5):705-11. PubMed ID: 15734614
[TBL] [Abstract][Full Text] [Related]
29. [Hyperuricemia].
Chizyński K; Rózycka M
Pol Merkur Lekarski; 2005 Nov; 19(113):693-6. PubMed ID: 16498814
[TBL] [Abstract][Full Text] [Related]
30. Serum uric acid independently predicts cardiovascular events in advanced nephropathy.
Kanbay M; Yilmaz MI; Sonmez A; Solak Y; Saglam M; Cakir E; Unal HU; Arslan E; Verim S; Madero M; Caglar K; Oguz Y; McFann K; Johnson RJ
Am J Nephrol; 2012; 36(4):324-31. PubMed ID: 23007099
[TBL] [Abstract][Full Text] [Related]
31. Association Between Hyperuricemia and Major Adverse Cardiac Events in Patients with Acute Myocardial Infarction.
Ranjith N; Myeni NN; Sartorius B; Mayise C
Metab Syndr Relat Disord; 2017 Feb; 15(1):18-25. PubMed ID: 27937806
[TBL] [Abstract][Full Text] [Related]
32. Serum uric acid levels and renal damage in hyperuricemic hypertensive patients treated with renin-angiotensin system blockers.
Berni A; Boddi M; Fattori EB; Cecioni I; Berardino S; Montuschi F; Chiostri M; Poggesi L
Am J Hypertens; 2010 Jun; 23(6):675-80. PubMed ID: 20203626
[TBL] [Abstract][Full Text] [Related]
33. Hyperuricemia and hypertension.
Feig DI
Adv Chronic Kidney Dis; 2012 Nov; 19(6):377-85. PubMed ID: 23089272
[TBL] [Abstract][Full Text] [Related]
34. Uric acid in hypertension and cardiovascular disease.
Alderman M
Can J Cardiol; 1999 Nov; 15 Suppl F():20F-2F. PubMed ID: 10579748
[TBL] [Abstract][Full Text] [Related]
35. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
Johnson RJ; Kang DH; Feig D; Kivlighn S; Kanellis J; Watanabe S; Tuttle KR; Rodriguez-Iturbe B; Herrera-Acosta J; Mazzali M
Hypertension; 2003 Jun; 41(6):1183-90. PubMed ID: 12707287
[TBL] [Abstract][Full Text] [Related]
36. Losartan versus atenolol-based antihypertensive treatment reduces cardiovascular events especially well in elderly patients: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Ruwald AC; Westergaard B; Sehestedt T; Kjeldsen SE; Lindholm LH; Wachtell K; Devereux RB; Ibsen H; Nieminen MS; Dahlöf B; Olsen MH
J Hypertens; 2012 Jun; 30(6):1252-9. PubMed ID: 22499288
[TBL] [Abstract][Full Text] [Related]
37. Relationship between serum uric acid and all-cause and cardiovascular mortality in patients treated with peritoneal dialysis.
Xia X; He F; Wu X; Peng F; Huang F; Yu X
Am J Kidney Dis; 2014 Aug; 64(2):257-64. PubMed ID: 24176223
[TBL] [Abstract][Full Text] [Related]
38. The role of uric acid in stroke: the issue remains unresolved.
Dimitroula HV; Hatzitolios AI; Karvounis HI
Neurologist; 2008 Jul; 14(4):238-42. PubMed ID: 18617849
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of benzbromarone in hyperuricemic patients associated with chronic kidney disease.
Fujimori S; Ooyama K; Ooyama H; Moromizato H
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1035-8. PubMed ID: 22132953
[TBL] [Abstract][Full Text] [Related]
40. The problem of cardio-renal diseases in patients with gout.
Ferri C
Curr Med Res Opin; 2017 Nov; 33(sup3):9-13. PubMed ID: 28952391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
